| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |